Our goal is to develop AI technologies that will change the landscape of healthcare and the life sciences. This includes the whole span from the discovery of biological mechanisms to early disease diagnostics, drug discovery, care personalization and management. Building on MIT’s pioneering history in artificial intelligence and life sciences, we are working on algorithms suitable for modeling biological and clinical data across a range of modalities including imaging, text and genomics.
While achieving this goal, we strive to make new discoveries in machine learning, biology, chemistry and clinical sciences, and translate our discoveries into technologies that can improve people’s lives. While the Jameel Clinic focuses primarily on AI and Health, other research labs and centers affiliated with EECS have groups engaged in AI for healthcare and life sciences, including IMES, CSAIL, LIDS, and the Eric and Wendy Schmidt Center at the Broad Institute.
Latest news in AI for healthcare and life sciences
MIT Sea Grant works with the Woodwell Climate Research Center and other collaborators to demonstrate a deep learning-based system for fish monitoring.
The award is given annually to an outstanding contributor to education from among the faculty members who are being proposed for promotion to associate professor without tenure.
Researchers at MIT, Mass General Brigham, and Harvard Medical School developed a deep-learning model to forecast a patient’s heart failure prognosis up to a year in advance.
By providing holistic information on a cell, an AI-driven method could help scientists better understand disease mechanisms and plan experiments.
New research demonstrates how AI models can be tested to ensure they don’t cause harm by revealing anonymized patient health data.